(Q34551534)

3 August 2017

title

Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome (English)

1 reference

3 August 2017

1 reference

Donato Rigante

1

1 reference

3 August 2017

Valentina Ansuini

2

1 reference

3 August 2017

Barbara Bertoni

3

1 reference

3 August 2017

Anna Lisa Pugliese

4

1 reference

3 August 2017

Laura Avallone

5

1 reference

3 August 2017

Gilda Federico

6

1 reference

3 August 2017

Achille Stabile

7

1 reference

3 August 2017

publication date

27 July 2006

1 reference

Rheumatology International

3 August 2017

published in

1 reference

3 August 2017

volume

27

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

97-100

1 reference

https://scigraph.springernature.com/pub.10.1007/s00296-006-0164-x

3 August 2017

exact match

0 references

cites work

Hyperimmunoglobulinaemia D and periodic fever: a new syndrome

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00296-006-0164-X

Mevalonate kinase deficiency: Evidence for a phenotypic continuum.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00296-006-0164-X

Mevalonate kinase deficiency and Dutch type periodic fever.

21 January 2018

1 reference

12 December 2020

Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome

1 reference

12 December 2020

Non-steroidal anti-inflammatory drugs in the treatment of hyper-IgD syndrome

1 reference

12 December 2020

MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever

1 reference

12 December 2020

Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist

1 reference

12 December 2020

Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model.

1 reference

12 December 2020

Dramatic improvement with anakinra in a case of chronic infantile neurological cutaneous and articular (CINCA) syndrome

1 reference

12 December 2020

Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands

1 reference

12 December 2020

Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome

1 reference

12 December 2020

Kineret: efficacy and safety in daily clinical practice: an interim analysis of the Kineret response assessment initiative (kreative) protocol.

1 reference

12 December 2020

Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Glucocorticoids but not NSAID abort attacks in hyper-IgD and periodic fever syndrome.

1 reference

12 December 2020

Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra

1 reference

12 December 2020

The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis

1 reference

12 December 2020

10.1007/S00296-006-0164-X

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1035353093

0 references

1 reference